Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial)

Bron
NPJ breast cancer - ISSN 2374-4677-10:1 (2024) p. 1-10
Auteur(s)
    Magdalena Mileva, Elisabeth G.E. de Vries, Thomas Guiot, Zena Wimana, Anne-Leen Deleu, Carolien P. Schroder, Yolene Lefebvre, Marianne Paesmans, Sigrid Stroobants, Manon Huizing, Philippe Aftimos, Jolien Tol, Winette T.A. van der Graaf, Wim J.G. Oyen, Danielle J. Vugts, C. Willemien Menke-van der Houven van Oordt, Adrienne H. Brouwers, Martine Piccart-Gebhart, Patrick Flamen, Geraldine Gebhart

Design, synthesis, and evaluation of Trans-cyclooctene (TCO) and cis-dioxolane fused TCO (d-TCO) probes for bioorthogonal pretargeted PET imaging

Bron
Antwerp, University of Antwerp, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, Department of Pharmaceutical Sciences, 2024,IX, 244 p.